Effects of Semisupervised Exercise Training on Health Outcomes in People With Lung or Head and Neck Cancer: Protocol for a Randomized Controlled Trial

Imagem de Miniatura
Arquivos
art_GRIGOLETTO_Effects_of_Semisupervised_Exercise_Training_on_Health_Outcomes_2023.PDF (415.82 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
JMIR PUBLICATIONS, INC
Autores
GRIGOLETTO, Isis
CAVALHERI, Vinicius
GOBBO, Luis Alberto
POZO, Karina
FILHO, Enio Rodrigues Maia
RIBEIRO, Diogo Goncalves
IELO, Nara
RAMOS, Ercy Mara Cipulo
Citação
JMIR RESEARCH PROTOCOLS, v.12, article ID e43547, 10p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Lung or head and neck cancers are known for their high prevalence and mortality rates. Chemotherapy and radiotherapy are usually recommended as cancer treatment for these malignancies; however, they can negatively impact both the physical and mental status of patients. Hence, it is reasonable to consider resistance and aerobic exercise training to prevent these negative health outcomes. Further, several factors prevent patients from attending outpatient exercise training programs, and, therefore, a semisupervised home-based exercise training program may be seen as a well-accepted alternative.Objective: The aim of this study will be to investigate the effects of a semisupervised home-based exercise training program on physical performance, body composition, and self-reported outcomes; changes in the initial cancer treatment dose prescribed; number of hospitalizations at 3, 6, and 9 months; and 12-month survival in people with primary lung or head and neck cancer.Methods: Participants will be randomly allocated to the training group (TG) or control group (CG). The TG will undergo semisupervised home-based resistance and aerobic exercise training throughout their cancer treatment. The resistance training will be performed using elastic bands (TheraBand) twice a week. The aerobic training (ie, brisk walk) will be performed for at least 20 minutes per day outdoors. The equipment and tools used during the training sessions will be provided. This intervention will start the week before treatment commencement, will be performed throughout the duration of the treatment, and will continue for 2 weeks after treatment completion. The CG will undergo usual care (ie, cancer treatment with no formal exercise prescription). Assessments will take place 2 weeks before the beginning of the usual cancer treatment and 2 weeks after treatment completion. The measures of physical function (peripheral muscle strength, functional exercise capacity, and physical activity), body composition, and self-reported outcomes (symptoms of anxiety and depression, health-related quality of life, and symptoms related to the disease and treatment) will be collected. We will report on any change in the initial cancer treatment dose prescribed; number of hospitalizations at 3, 6, and 9 months; and 12-month survival.Results: In February 2021, the clinical trial registration was approved. Recruitment and data collection for the trial are ongoing (as of April 2023, 20 participants had already been randomized), and findings of this study are likely to be published late in 2024.Conclusions: This exercise training as a complementary treatment for patients with cancer is likely to promote positive effects on the health outcomes assessed, over and above any change in the CG, and prevent the reduction of initial cancer treatment dose prescribed. If these positive effects are shown, they will likely impact long-term outcomes such as hospitalizations and 12-month survival.Trial Registration: Brazilian Clinical Trials Registry (ReBEC) RBR-5cyvzh9; https://ensaiosclinicos.gov.br/rg/RBR-5cyvzh9.International Registered Report Identifier (IRRID): PRR1-10.2196/43547(JMIR Res Protoc 2023;12:e43547) doi: 10.2196/43547
Palavras-chave
lung neoplasms, head and neck neoplasms, drug therapy, radiotherapy, exercise, muscle strength, lung cancer, neck cancer, head cancer, aerobic exercise, pulmonary, neoplasm, ENDT, ear nose throat, ear, nose, and throat, RCT, oncology, outpatient, cancer treatment, Eastern Cooperative Oncology Group, ECOG, HRQoL, quality of life, QoL, physical activity
URI
https://observatorio.fm.usp.br/handle/OPI/58122
Referências
  1. Adamsen L, 2012, SCAND J MED SCI SPOR, V22, P804, DOI 10.1111/j.1600-0838.2011.01323.x
  2. Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9
  3. Andersen AH, 2011, ACTA ONCOL, V50, P307, DOI 10.3109/0284186X.2010.529461
  4. [Anonymous], 2004, Clinical practice guidelines for support of the family in the patient-centered intensive care unit: American College of Critical Care Medicine Task Force
  5. Bade BC, 2015, J THORAC ONCOL, V10, P861, DOI 10.1097/JTO.0000000000000536
  6. Bélanger LJ, 2012, CANCER NURS, V35, P48, DOI 10.1097/NCC.0b013e318210220a
  7. Berger AM, 2015, J NATL COMPR CANC NE, V13, P1012, DOI 10.6004/jnccn.2015.0122
  8. Britto RR, 2013, BRAZ J PHYS THER, V17, P556
  9. Brown JC, 2018, J CACHEXIA SARCOPENI, V9, P664, DOI 10.1002/jcsm.12305
  10. Cavalheri V, 2017, BRAZ J PHYS THER, V21, P58, DOI 10.1016/j.bjpt.2016.12.005
  11. Cheville AL, 2013, J PAIN SYMPTOM MANAG, V45, P811, DOI 10.1016/j.jpainsymman.2012.05.006
  12. Chow LQM, 2020, NEW ENGL J MED, V382, P60, DOI 10.1056/NEJMra1715715
  13. Ramos EMC, 2014, CLIN REHABIL, V28, P1096, DOI 10.1177/0269215514527842
  14. Freire APCF, 2022, PHYSIOTHER THEOR PR, V38, P14, DOI 10.1080/09593985.2020.1716422
  15. Crook S, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01871-2016
  16. Dhillon HM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-572
  17. Duffy MJ, 2008, CLIN CHEM, V54, P1770, DOI 10.1373/clinchem.2008.110056
  18. Edbrooke L, 2019, THORAX, V74, P787, DOI 10.1136/thoraxjnl-2018-212996
  19. Fayers PA, 2001, EORTC QLQ C30 SCORIN, P2
  20. Ferguson B, 2014, J CAN CHIROPR ASS, V58, P328
  21. Granger CL, 2016, J PHYSIOTHER, V62, P60, DOI 10.1016/j.jphys.2016.02.010
  22. Hagströmer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898
  23. Hardcastle SJ, 2018, SUPPORT CARE CANCER, V26, P1289, DOI 10.1007/s00520-017-3952-9
  24. Hart NH, 2017, CURR OPIN SUPPORT PA, V11, P247, DOI 10.1097/SPC.0000000000000276
  25. Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]
  26. Henke CC, 2014, SUPPORT CARE CANCER, V22, P95, DOI 10.1007/s00520-013-1925-1
  27. Heywood R, 2018, ARCH PHYS MED REHAB, V99, P2595, DOI 10.1016/j.apmr.2018.04.008
  28. Hofman M, 2007, ONCOLOGIST, V12, P4, DOI 10.1634/theoncologist.12-S1-4
  29. Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314
  30. Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
  31. Kuehr L, 2014, MED SCI SPORT EXER, V46, P656, DOI 10.1249/MSS.0000000000000158
  32. Trinh L, 2012, SUPPORT CARE CANCER, V20, P1709, DOI 10.1007/s00520-011-1264-z
  33. Nicklasson M, 2007, QUAL LIFE RES, V16, P1019, DOI 10.1007/s11136-007-9210-8
  34. Nordstrand N, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-7
  35. Papadopoulos D, 2018, J PAIN SYMPTOM MANAG, V55, P1364, DOI 10.1016/j.jpainsymman.2017.12.491
  36. PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
  37. PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1
  38. Randomisation and Code Break, SEALED ENVELOPE
  39. Silva IG, 2018, PULMONOLOGY, V24, P354, DOI 10.1016/j.pulmoe.2018.09.005
  40. Silverman DA, 2020, HEAD NECK-J SCI SPEC, V42, P1218, DOI 10.1002/hed.26217
  41. Speed-Andrews AE, 2009, CURR SPORT MED REP, V8, P176, DOI 10.1249/JSR.0b013e3181ae98f3
  42. Squires RW, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0681-2
  43. van Waart H, 2015, J CLIN ONCOL, V33, P1918, DOI 10.1200/JCO.2014.59.1081
  44. Vanderbyl BL, 2017, SUPPORT CARE CANCER, V25, P1749, DOI 10.1007/s00520-017-3579-x
  45. Velthuis MJ, 2010, CLIN ONCOL-UK, V22, P208, DOI 10.1016/j.clon.2009.12.005
  46. Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913
  47. Wen Hong, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P27
  48. ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros
Artigos e Materiais de Revistas Científicas - LIM/54
Artigos e Materiais de Revistas Científicas - ODS/03